01 August 2021,   15:33
WHO sets dates for reviews of Sinopharm and Sinovac COVID-19 vaccines

Technical experts at the World Health Organization (WHO) will review on April 26 Chinese drugmaker Sinopharm"s COVID-19 vaccine for possible emergency use listing, to be followed by the Sinovac (SVA.O) jab on May 3, writes Reuters.

“We would expect a decision a couple of days later”, - the WHO said in response to a Reuters query.

So far COVID-19 vaccines made by Pfizer (PFE.N) AstraZeneca (AZN.L) and Johnson & Johnson (JNJ.N) have received a WHO listing - an endorsement of their safety and efficacy that helps to guide countries" regulatory agencies.